Patents
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
08/2004
08/26/2004WO2004071345A2 A device and method for the determination of lithium ion concentration in a biological fluid
08/26/2004US20040167141 Anticancer agents; antidiabetic agents; Alzheimer's disease
08/26/2004US20040167106 Prevention of ovarian cancer by administration of a Vitamin D compound
08/26/2004CA2513220A1 Benzamide derivatives as oxytocin agonists and vasopressin antagonists
08/25/2004EP1449844A1 benzamide derivatives as oxytocin agonists and vasopressin antagonists
08/25/2004EP1448562A1 Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors
08/25/2004EP1448547A1 Pyridine derivatives as nmda receptor ligands
08/25/2004EP1448537A2 Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses
08/25/2004EP1083903B1 Bridged indenopyrrolocarbazoles
08/25/2004EP0854869B1 Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation
08/25/2004CN1524003A Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent
08/25/2004CN1523986A Substituted oxazolidinones for combinational therapy
08/24/2004US6780872 Asthma; antiepileptic agents; sexual disorders
08/19/2004WO2004069845A1 Solid state fermentation and fed batch for the production of an immunosuppressant
08/19/2004WO2004069844A1 Novel tricyclic oxazepine derivatives, method for production thereof and pharmaceutical compositions comprising the same
08/19/2004WO2004069832A2 Antibacterial agents
08/19/2004WO2004069823A1 Inhibitors of histone deacetylase
08/19/2004WO2004069245A1 Oxazolidinone derivates n-substituted by a tricyclic ring, for use as antibacterial agents
08/19/2004US20040162299 Substituted quinazolines and analogs and the use thereof
08/19/2004US20040162279 Tricyclic tetrahydroquinoline antibacterial agents
08/19/2004US20040161854 Device and method for the determination of lithium ion concentration in a biological fluid
08/19/2004CA2515311A1 Antibacterial agents
08/19/2004CA2514241A1 Oxazolidinone derivates n-substituted by a tricyclic ring, for use as antibacterial agents
08/18/2004EP1446407A2 (pyrido/thieno)-(f)-oxazepin-5-one derivatives as positive modulators of the ampa receptor
08/18/2004EP1446391A2 Preparation and use of carbohydrate-based ring structures with antimicrobial and cytostatic activity
08/18/2004EP1446125A1 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity
08/18/2004EP1315739B1 Method for binding, in solution, a peptide and a lipophilic vector and uses thereof
08/18/2004EP1284978B1 Process for the purification of a salt of clavulanic acid
08/18/2004CN1162434C Improved process for rifampin high-density raw powder I type crystal
08/18/2004CN1162429C Tricyclic vasopressin agonists
08/18/2004CN1162410C Insecticidal dihydro-oxadiazines, -thiadiazines and triazines
08/17/2004US6777557 Method and composition for rejuvenating cells, tissues organs, hair and nails
08/17/2004US6777416 Isoxazolo pyrimidinones and the use thereof
08/17/2004US6777410 Isoindole derivatives
08/17/2004US6777406 Substituted pyrroloquinolines and pyridoquinolines as serotinin agonists and antagonists
08/17/2004US6776796 Antiinflammatory drug and delivery device
08/17/2004CA2133177C Rapamycin formulations for oral administration
08/13/2004WO2004072084A1 Salt of benzosulfonic acid containing clopidogrel and use thereof for the production of pharmaceutical formulations
08/13/2004CA2468089A1 Salt of benzenesulfonic acid with clopidogrel and its use for producing pharmaceutical formulations
08/12/2004WO2004056799A3 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
08/12/2004US20040157893 Pyrazole compounds useful as protein kinase inhibitors
08/12/2004US20040157876 Solid dosage forms; melt granulation
08/12/2004US20040157840 Rifalazil compositions and therapeutic regimens
08/12/2004US20040157831 Therapeutic 5-HT ligand compounds
08/11/2004EP1444229A1 Pyrazole derivatives as psychopharmaceuticals
08/11/2004EP1443822A1 Substituted thien-3-yl-sulfonylamino(thio)carbonyl-triazolin(thi)ones
08/11/2004CN1520417A New process for prepn. of oxabispidines
08/11/2004CN1520412A New derivatives of oxazolidinones as antibacterial agents
08/11/2004CN1161360C Tetrazole-containg rapamycin analogs with shortened half-lives
08/11/2004CN1161359C Biindolelinenaphtho-spiroxazine compound, its preparing process and products containing it
08/11/2004CN1161117C Medicinal compositions
08/10/2004US6774134 For therapy of respiratory syncytial virus infection
08/10/2004US6774126 Pyrrolo[1,2-b][1,2,4]oxadiazine diones useful as nitric oxide synthase inhibitors
08/10/2004CA2187024C Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them
08/05/2004WO2004064972A2 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
08/05/2004WO2004064778A2 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
08/05/2004WO2004064730A2 Compounds, compositions and methods
08/05/2004US20040152892 Oxazolo-and furopyrimidines and their use in medicaments against tumors
08/05/2004US20040152889 Process for the preparation of benazepril
08/05/2004US20040152701 Reacting n-methylpiperazine with 9,10-difluoro-7-oxo-2,3-dihydropyrido(1,2,3,d,e)(1,4)benzoxazine-6-carboxylic acid in acetonitrile; silvent extraction, refluxing
08/05/2004US20040152697 Pyrrolidin-2-one derivatives as inhibitors of factor xa
08/05/2004CA2512546A1 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
08/04/2004EP1441737A1 Staurosporine derivatives as inhibitors of flt3 receptor tyrosine kinase activity
08/04/2004EP1441721A2 Use of endothelin receptor antagonists in the treatment of tumour diseases
08/04/2004EP1064256B1 Bicyclo [2.2.1] heptanes and related compounds
08/04/2004CN1160360C Oxazonaphthalone compounds for enhancing synaptic response
08/04/2004CN1160088C Extraction method of pharmaceutical composition and cosmetic composition
08/03/2004US6770664 Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
08/03/2004US6770647 Osteoporosis; rheumatic diseases
08/03/2004US6770596 Fused tricyclic compounds, process for their preparation, and herbicidal compositions containing them
08/03/2004US6770451 Biological conjugation with an enzyme donor, enzyme acceptor, and a substrate, competetive binding, detecting kinases or phosphatases
07/2004
07/29/2004WO2004063198A1 Diazepinoindole derivatives as kinase inhibitors
07/29/2004WO2004063190A1 Fused heterocyclic derivates as ppar modulators
07/29/2004WO2004063155A1 Fused heterocyclic derivatives as ppar modulators
07/29/2004WO2004062590A2 Bicyclic carbohydrates as antiprotozoal bioactive for the treatment of infections caused by parasites
07/29/2004WO2004035536A3 Azo compounds for type i phototherapy
07/29/2004WO2004014868A8 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors
07/29/2004US20040147580 Therapy for bacteria infections
07/29/2004US20040147568 Obesity; dietetics; adjust density of bones, muscles
07/29/2004US20040147545 Therapy for infection
07/29/2004US20040147541 Using rapamycin; antitumor agents; angiogenesis inhibitors
07/29/2004US20040147523 Premenstrual syndrome; anxiolytic agents; attention deficit disorders; obsessive compulsive disorders; eating disorders; alcoholism; sexual disorders
07/29/2004US20040147514 Applying to plants
07/29/2004CA2510516A1 Fused heterocyclic derivatives as ppar modulators
07/29/2004CA2509202A1 Fused heterocyclic derivatives as ppar modulators
07/28/2004EP1140862A4 THROMBIN OR FACTOR Xa INHIBITORS
07/28/2004CN1516701A (Pyrido/thieno)-[f]-oxazepin-5-one derivatives as AMPA receptor positive regulator
07/28/2004CN1516695A Arylsulfonamides as antiviral agents
07/28/2004CN1159315C 4,5-pyrrolo-oxindoles
07/22/2004WO2004060283A2 Nitrosated and nitrosylated rapamycin compounds, compositions and methods of use
07/22/2004US20040143115 e.g., 1-[2-Benzoxazol-2-ylaminomethyl)-piperidin-1-yl]-1-(2-methyl-5phenyl-thiazol4-yl)-methanone; used to treat disorders where an antagonist of a human orexin receptor is required
07/22/2004US20040143000 3,7-diazabicyclo [3.3.1] formulations as antiarhythmic compounds
07/22/2004US20040142999 Novel compounds and compositions as cathepsin inhibitors
07/22/2004US20040142953 Inhibitors of histone deacetylase
07/22/2004US20040142945 Antiarthritic agents; multiple sclerosis ; organ rejection ; antidiabetic agents; inflammatory bowel disorders; antiischemic agents; skin disorders
07/22/2004US20040142926 5HT1A antagonist; obsessive-compulsive disorder, panic attacks, generalized anxiety disorder, and social anxiety disorder
07/21/2004EP1438314A1 A process for preparing enantiomerically pure alpha-phenyl-aplpha(6,7-dihydro-4h-thieno 3,2-c pyridin-5-yl)-acetic acid derivatives
07/21/2004EP1438288A1 Substituted thioacetamides
07/21/2004EP1438048A1 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors
07/21/2004CN1514839A 3,7-diazybicyclo [3.3.1] for mulations as antiarrhytmic compounds